Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - LeMaitre Vascular makes appointment:

This article was originally published in Clinica

Executive Summary

Russell Hays will rejoin the board of directors vascular device company LeMaitre Vascular (Burlington, Massachusetts) as a class II director on January 1 2008. He will also be chair of the firm's nominating and corporate governance committees. The firm believes that Mr Hays, who was on the firm's board during 2003-05, will help the company "regain compliance with the marketplace rules of the Nasdaq" and move it to its next level of growth. Most recently, Mr Hays was the president, CEO and chairman of Biosource International (biomedical research tools).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel